iTRAQ-based quantitative proteomic analysis and bioinformatics study of proteins in pterygia

Area of Science:

• Ophthalmology
• Proteomics
• Molecular Biology

Background:

• Pterygia are wing-shaped fibrovascular growths on the conjunctiva.
• Understanding the molecular mechanisms of pterygia is crucial for developing effective treatments.

Purpose of the Study:

• To analyze the proteomic profile of pterygia tissue.
• To identify differentially expressed proteins and investigate their potential roles in pterygia pathogenesis.
• To establish a foundation for a better understanding of pterygia.

Main Methods:

• Comparative proteomic analysis using Isobaric Tags for Relative and Absolute Quantitation (iTRAQ) coupled with 2D-liquid chromatography-tandem mass spectrometry (2DLC-MS/MS).
• Proteins were extracted from pterygia and healthy conjunctiva tissues of 10 patients.
• Gene Ontology (GO) analysis was performed using the DAVID database, and key proteins were validated by Western blot.

Main Results:

• 156 proteins showed significant differential expression between pterygia and healthy conjunctiva (138 up-regulated, 18 down-regulated).
• Identified proteins were primarily involved in cellular processes, metabolic processes, and developmental processes.
• Matrix Metalloproteinase 10 (MMP-10) and CD34 were identified as potentially significant proteins, confirmed to be up-regulated in pterygia tissue via Western blot.

Conclusions:

• This study is the first to utilize iTRAQ technology to identify 156 proteins associated with pterygia.
• The findings provide novel insights into the molecular underpinnings of pterygia.
• The identified proteins, particularly MMP-10 and CD34, may serve as potential therapeutic targets for pterygia.